Detalhe da pesquisa
1.
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL.
Nature
; 609(7926): 369-374, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36045296
2.
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
N Engl J Med
; 390(16): 1467-1480, 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38657244
3.
A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)-associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapy.
Cytotherapy
; 25(11): 1167-1175, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37480884
4.
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia.
Mol Ther
; 29(2): 645-657, 2021 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33278564
5.
A novel human anti-TIGIT monoclonal antibody with excellent function in eliciting NK cell-mediated antitumor immunity.
Biochem Biophys Res Commun
; 534: 134-140, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33341068
6.
Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds.
Regul Toxicol Pharmacol
; 114: 104665, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32334036
7.
The Chimeric Chaoyang-Zika Vaccine Candidate Is Safe and Protective in Mice.
Vaccines (Basel)
; 12(2)2024 Feb 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38400198
8.
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.
Cell Transplant
; 33: 9636897231221887, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38183241
9.
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism.
Cell Rep Med
; 5(2): 101400, 2024 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38307031
10.
Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
J Immunol Methods
; 513: 113427, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36652969
11.
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial.
Lancet Haematol
; 10(2): e107-e116, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36725117
12.
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma.
Cell Transplant
; 32: 9636897231194265, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37667507
13.
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy.
Bone Marrow Transplant
; 58(6): 701-709, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37002410
14.
Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study.
EClinicalMedicine
; 60: 102010, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37251628
15.
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.
Front Immunol
; 14: 1125357, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37215107
16.
Rapid Generation of Recombinant Flaviviruses Using Circular Polymerase Extension Reaction.
Vaccines (Basel)
; 11(7)2023 Jul 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37515065
17.
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways.
Adv Sci (Weinh)
; 9(9): e2103508, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35032108
18.
BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System Involvement.
J Immunother
; 45(1): 25-34, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34874329
19.
Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E.
Int Immunopharmacol
; 113(Pt A): 109308, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36274487
20.
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study.
Cell Res
; 32(11): 995-1007, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36151216